Browse drugs

…ement.Results A total of 1,992 drug interactions were analysed: apixaban 531 (26.7%), dabigatran 492 (24.7%), edoxaban 411 (20.6%), riva…

…is is a rarely reported yet potentially fatal adverse effect of apixaban. This case involves a patient in her 60s who presented with lef…

…entified, of which 149 (7.5%) involved herbal or food products: apixaban 42 (28.2%), dabigatran 42 (28.2%), edoxaban 23 (15.4%), rivarox…

…ent with national prescribing guidance (to switch patients onto edoxaban).Intervention Complex intervention including a SMOR embedded wi…

…gents were (dabigatran and warfarin) and were not (apixaban and rivaroxaban) available.Methods We included patients with anticoagulation-re…

…314 (28.9%), edoxaban 271 (24.9%), rivaroxaban 258 (23.7%), and apixaban 245 (22.5%). Overall agreement was low (percent agreement 49.1%…

…thematous (SLE). We report a case of recurrent ALP treated with anifrolumab.Methods A 47-year-old man presented in August 2022 with progres…

…tion. Anticoagulant use was defined as active administration of warfarin, heparin, apixaban, dabigatran, or rivaroxaban at time of prese…

… and median baseline NIHSS score was 6. Only 1/6 patient was on aspirin and 1/6 was on apixaban pre-op and rest were anti-thrombotic na…

…and a non-vitamin K antagonist OAC. In this patient population, clopidogrel is the P2Y12 inhibitor of choice given the significantly lower …

…y confirmed bilateral pulmonary emboli and she was treated with apixaban. After discontinuing anticoagulation prematurely, she re-presen…

…receptor targeted agents (ARTAs) used to treat prostate cancer, enzalutamide1 is a valid option at several stages of the disease. In terms of…